R-albuterol: Phase III study

The three-way crossover, double-blind, parallel group, bronchodilation study will include more than 300 patients at 20 sites around the world.

The company also will conduct bronchoprovocation studies designed to show that R-albuterol lacks the bronchial hyperreactivity side effects of the racemic compound. ...